May 06, 2024
BioIVT Highlights its Focus on Cell and Gene Therapy in Spring Industry Events
Apr 04, 2024
BioIVT to Participate at the American Association for Cancer Research Annual Meeting 2024
Mar 07, 2024
BioIVT to Showcase Leading Products for Toxicological Studies at the SOT ToxExpo 2024
Feb 22, 2024
BioIVT Announces Expansive Fresh Leukopak Capability in Europe
Feb 15, 2021
BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research
Jul 28, 2020
BioIVT Supports COVID-19 Drug, Diagnostic and Vaccine Researchers by Expanding its Inventory of Patient Plasma, Serum and Saliva Specimens
Apr 06, 2020
BioIVT Opens New Blood Donor Center to Support Boston-area Research into COVID-19 Therapies, Vaccines and Diagnostics
Mar 03, 2020
BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations
Aug 06, 2019
BioIVT Acquires Keystone Biologicals, Expands its Offering of Disease-state Biospecimens
Mar 06, 2019
BioIVT Launches Its XPRESSWAY® Profile Safety Package, a Gene Expression Reference Guide Designed to Improve Drug Safety Analyses
Nov 05, 2018
BioIVT Acquires Biological Specialty Corporation, Adds Donor Centers and Increases Its Immune Cell Capacity
Oct 16, 2018
BioIVT Introduces New Quality Management System to Maintain Highest Quality Biospecimens and Drug Development Research Services
Oct 08, 2018
BioIVT Acquires UK-based Clinical Trials Laboratory Services
Mar 27, 2018
BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios
Jan 11, 2018
BioIVT Launches Scientific Advisory Board, Expands Drug Development Expertise
Sep 07, 2017
BioIVT Acquires Qualyst Transporter Solutions, Enables Researchers to Predict New Drug Candidates' Impact on the Liver